MA34392B1 - Pyrimidines en tant qu'agents antiviraux - Google Patents

Pyrimidines en tant qu'agents antiviraux

Info

Publication number
MA34392B1
MA34392B1 MA35586A MA35586A MA34392B1 MA 34392 B1 MA34392 B1 MA 34392B1 MA 35586 A MA35586 A MA 35586A MA 35586 A MA35586 A MA 35586A MA 34392 B1 MA34392 B1 MA 34392B1
Authority
MA
Morocco
Prior art keywords
compounds
pyrimidines
antiviral agents
compositions
formula
Prior art date
Application number
MA35586A
Other languages
English (en)
Inventor
Kerim Babaoglu
Constantine G Boojamra
Eugene J Eisenberg
Hon Chung Hui
Richard L Mackman
Jay P Parrish
Michael Sangi
Oliver L Saunders
Dustin Siegel
David Sperandio
Hai Yang
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of MA34392B1 publication Critical patent/MA34392B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des composés de formule I ou de formule II : (I), (II) ou un sel ou un ester pharmaceutiquement acceptables de ceux-ci, tels que décrits dans le présent document. Les composés et compositions de ceux-ci sont utiles pour le traitement d'infections par les virus Pneumovirinae. Les composés, compositions et procédés décrits sont particulièrement utiles dans le traitement d'infections par le virus respiratoire syncytial humain.
MA35586A 2010-06-24 2011-06-23 Pyrimidines en tant qu'agents antiviraux MA34392B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35812210P 2010-06-24 2010-06-24
PCT/US2011/041688 WO2011163518A1 (fr) 2010-06-24 2011-06-23 Pyrazolo[1,5-a]pyrimidines en tant qu'agents antiviraux

Publications (1)

Publication Number Publication Date
MA34392B1 true MA34392B1 (fr) 2013-07-03

Family

ID=44509853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA35586A MA34392B1 (fr) 2010-06-24 2011-06-23 Pyrimidines en tant qu'agents antiviraux

Country Status (38)

Country Link
US (7) US8486938B2 (fr)
EP (2) EP2585467B1 (fr)
JP (4) JP5878171B2 (fr)
KR (1) KR101970837B1 (fr)
CN (2) CN105481866A (fr)
AP (1) AP3417A (fr)
AR (1) AR082275A1 (fr)
AU (1) AU2011270798B2 (fr)
BR (1) BR112012033117A2 (fr)
CA (1) CA2800834C (fr)
CL (1) CL2012003632A1 (fr)
CO (1) CO6640297A2 (fr)
CR (1) CR20130023A (fr)
CY (1) CY1118239T1 (fr)
DK (1) DK2585467T3 (fr)
EA (2) EA201591390A1 (fr)
EC (2) ECSP13012400A (fr)
ES (2) ES2700542T3 (fr)
HK (3) HK1184157A1 (fr)
HR (1) HRP20160431T1 (fr)
HU (1) HUE029174T2 (fr)
IL (2) IL223253B (fr)
MA (1) MA34392B1 (fr)
ME (1) ME02397B (fr)
MX (1) MX2012015292A (fr)
NZ (1) NZ604345A (fr)
PE (1) PE20130395A1 (fr)
PL (1) PL2585467T3 (fr)
PT (1) PT3012258T (fr)
RS (1) RS54761B1 (fr)
SG (2) SG10201505022WA (fr)
SI (1) SI2585467T1 (fr)
SM (1) SMT201600155B (fr)
TW (3) TWI537272B (fr)
UA (1) UA112292C2 (fr)
UY (1) UY33467A (fr)
WO (1) WO2011163518A1 (fr)
ZA (1) ZA201209549B (fr)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2540867T3 (es) * 2010-02-26 2015-07-14 Mitsubishi Tanabe Pharma Corporation Compuestos de pirazolopirimidina y su uso como inhibidores de PDE10
ES2700542T3 (es) * 2010-06-24 2019-02-18 Gilead Sciences Inc Composición farmacéutica que comprende un derivado de pirazolo[1,5-A]pirimidina como un agente antiviral
EP2585462B1 (fr) 2010-06-24 2020-02-26 Takeda Pharmaceutical Company Limited Composés hétérocycliques condensés comme inhibiteurs de phosphodiestérases (pdes)
CA2816076C (fr) 2010-11-03 2020-07-14 Dow Agrosciences Llc Molecules de pyridyl-pyrazolyl
US9309250B2 (en) 2011-06-22 2016-04-12 Vertex Pharmaceuticals Incorporated Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors
JP5531066B2 (ja) * 2011-08-24 2014-06-25 田辺三菱製薬株式会社 ピラゾロピリミジン化合物及びｐｄｅ１０阻害剤としてのその使用
UA114611C2 (uk) 2011-10-26 2017-07-10 Дау Аґросаєнсиз Елелсі Пестицидні композиції і способи, що їх стосуються
PT2794611T (pt) 2011-12-22 2017-12-06 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas como agentes antivirais
IN2014DN09173A (fr) * 2012-04-17 2015-07-10 Gilead Sciences Inc
WO2013162715A2 (fr) 2012-04-27 2013-10-31 Dow Agrosciences Llc Compositions pesticides et procédés correspondants
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
US9708288B2 (en) 2012-04-27 2017-07-18 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
AU2013344716B2 (en) 2012-11-16 2018-03-01 University Health Network Pyrazolopyrimidine compounds
BR112015012454B1 (pt) 2012-12-07 2022-07-05 Vertex Pharmaceuticals Incorporated Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos
WO2014143241A1 (fr) 2013-03-15 2014-09-18 Vertex Pharmaceuticals Incorporated Composés utiles en tant qu'inhibiteurs de la kinase atr
EP2970286A1 (fr) 2013-03-15 2016-01-20 Vertex Pharmaceuticals Inc. Dérivés de pyrazolopyrimidine fusionnés utiles en tant qu'inhibiteurs de la kinase atr
US8969360B2 (en) 2013-03-15 2015-03-03 Vertex Pharmaceuticals Incorporated Compounds useful as inhibitors of ATR kinase
RU2019101889A (ru) 2013-03-15 2019-03-28 Версеон Корпорейшн Полизамещенные ароматические соединения в качестве ингибиторов сериновых протеаз
WO2014175370A1 (fr) * 2013-04-25 2014-10-30 塩野義製薬株式会社 Dérivé de pyrrolidine et composition pharmaceutique en contenant
SG11201600977XA (en) 2013-08-21 2016-03-30 Alios Biopharma Inc Antiviral compounds
US9044017B2 (en) 2013-10-17 2015-06-02 Dow Agrosciences Llc Processes for the preparation of pesticidal compounds
KR20160072154A (ko) 2013-10-17 2016-06-22 다우 아그로사이언시즈 엘엘씨 살충성 화합물의 제조 방법
WO2015058026A1 (fr) 2013-10-17 2015-04-23 Dow Agrosciences Llc Procédés de préparation de composés pesticides
CN105636446B (zh) 2013-10-17 2018-07-13 美国陶氏益农公司 制备杀虫化合物的方法
BR112016007518A2 (pt) 2013-10-17 2017-08-01 Dow Agrosciences Llc processos para a preparação de compostos pesticidas
EP3057429A4 (fr) 2013-10-17 2017-08-09 Dow AgroSciences LLC Procédés de préparation de de composés pesticides
CA2925953C (fr) 2013-10-17 2021-11-02 Dow Agrosciences Llc Procedes de preparation de composes pesticides
CA2926438A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procedes associes
TW201517797A (zh) 2013-10-22 2015-05-16 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（十一）
US9282740B2 (en) 2013-10-22 2016-03-15 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
WO2015061171A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procédés associés
TW201519779A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 協同性殺蟲組成物及相關方法（十二）
CA2927195A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides synergiques et procedes associes
CN105792650A (zh) 2013-10-22 2016-07-20 美国陶氏益农公司 协同杀虫组合物和相关方法
AU2014340437B2 (en) 2013-10-22 2017-09-07 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
CA2926433A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procedes associes
NZ720113A (en) 2013-10-22 2017-06-30 Dow Agrosciences Llc Synergistic pesticidal compositions and related methods
MX2016005324A (es) 2013-10-22 2016-08-12 Dow Agrosciences Llc Composiciones pesticidas y metodos relacionados.
WO2015061165A1 (fr) 2013-10-22 2015-04-30 Dow Agrosciences Llc Compositions pesticides et procédés associés
TW201519783A (zh) 2013-10-22 2015-06-01 Dow Agrosciences Llc 殺蟲組成物及相關方法（四）
JP2016538265A (ja) 2013-10-22 2016-12-08 ダウ アグロサイエンシィズ エルエルシー 相乗的有害生物防除組成物および関連する方法
KR102286233B1 (ko) 2013-10-22 2021-08-06 코르테바 애그리사이언스 엘엘씨 살충 조성물 및 관련 방법
RU2016119560A (ru) 2013-10-22 2017-11-28 ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи Синергетические пестицидные композиции и относящиеся к ним способы
EP3060050A4 (fr) 2013-10-22 2017-04-05 Dow AgroSciences LLC Compositions pesticides synergiques et procédés correspondants
CN105934435B (zh) 2013-12-06 2019-02-22 沃泰克斯药物股份有限公司 用作atr激酶抑制剂的化合物，其制备，及其放射性标记的衍生物
CN107074863B (zh) 2014-06-05 2019-12-03 沃泰克斯药物股份有限公司 Atr激酶抑制剂的制备方法及其不同的固体形式
GB201410817D0 (en) * 2014-06-17 2014-07-30 Ucb Biopharma Sprl And Katholieke Universiteit Leuven K U Leuven R & D Therapeutic agents
SG11201610500WA (en) 2014-06-17 2017-01-27 Vertex Pharma Method for treating cancer using a combination of chk1 and atr inhibitors
US20160022724A1 (en) * 2014-07-22 2016-01-28 Alios Biopharma, Inc. Methods for treating paramyxoviruses
AR098107A1 (es) 2014-07-31 2016-05-04 Dow Agrosciences Llc Proceso para la preparación de 3-(3-cloro-1h-pirazol-1-il)piridina
CN106488908A (zh) 2014-07-31 2017-03-08 美国陶氏益农公司 制备3‑(3‑氯‑1h‑吡唑‑1‑基)吡啶的方法
BR112017000565A2 (pt) 2014-07-31 2017-11-07 Dow Agrosciences Llc processo para a preparação de 3-(3-cloro-1h-pirazol-1-il)piridina
CA2957017A1 (fr) * 2014-08-05 2016-02-11 Alios Biopharma, Inc. Polytherapie pour traiter un paramyxovirus
CA2958058A1 (fr) 2014-08-19 2016-02-25 Dow Agrosciences Llc Procede de preparation de 3-(3-chloro-1h-pyrazol-1-yl)pyridine
JP2017528469A (ja) 2014-09-12 2017-09-28 ダウ アグロサイエンシィズ エルエルシー ３−（３−クロロ−１ｈ−ピラゾール−１−イル）ピリジンの調製方法
CN106687445A (zh) 2014-09-17 2017-05-17 维颂公司 作为丝氨酸蛋白酶抑制剂的吡唑基取代的吡啶酮化合物
CN107001377B (zh) * 2014-12-08 2019-09-10 爱尔兰詹森科学公司 对呼吸道合胞病毒(rsv)的复制具有抑制活性的哌啶取代的吡唑并[1,5-a]嘧啶衍生物
WO2016091791A1 (fr) * 2014-12-08 2016-06-16 Janssen Sciences Ireland Uc Dérivés tricycliques de pyrazolo [1,5-a] pyrimidine substitués par pipéridine, ayant une activité inhibitrice sur la réplication du virus respiratoire syncytial (rsv)
HUE056470T2 (hu) 2014-12-26 2022-02-28 Univ Emory Vírusellenes N4-Hidroxicitidin származékok
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
EP3261639B1 (fr) * 2015-02-27 2022-08-24 Verseon International Corporation Composés pyrazole substitués à utiliser en tant qu'inhibiteurs de sérine protéase
JP2018076234A (ja) * 2015-03-16 2018-05-17 大正製薬株式会社 ピラゾロ［１，５−ａ］ピリミジン化合物
JO3637B1 (ar) * 2015-04-28 2020-08-27 Janssen Sciences Ireland Uc مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv
EP3355926A4 (fr) 2015-09-30 2019-08-21 Vertex Pharmaceuticals Inc. Méthode de traitement du cancer utilisant une association d'agents endommageant l'adn et d'inhibiteurs de l'atr
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
EP3454862A4 (fr) 2016-05-10 2020-02-12 C4 Therapeutics, Inc. Dégronimères spirocycliques pour la dégradation de protéines cibles
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
WO2017197055A1 (fr) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Dégronimères hétérocycliques pour la dégradation de protéines cibles
MX2019002303A (es) 2016-08-31 2019-07-15 Agios Pharmaceuticals Inc Inhibidores de procesos metabolicos celulares.
WO2018125817A1 (fr) 2016-12-29 2018-07-05 Dow Agrosciences Llc Procédés de préparation de composés pesticides
EP3562807B1 (fr) 2016-12-29 2022-08-03 Corteva Agriscience LLC Procédés de préparation de composés pesticides
CN111386118B (zh) 2017-09-29 2023-05-09 英安塔制药有限公司 作为rsv抑制剂的组合药物剂
TW201932470A (zh) 2017-11-29 2019-08-16 愛爾蘭商健生科學愛爾蘭無限公司 具有抗ｒｓｖ活性之吡唑并嘧啶
GB2590198B (en) 2017-12-07 2022-02-23 Univ Emory N4-hydroxycytidine derivatives and anti-viral uses related thereto
US11491157B2 (en) 2018-01-31 2022-11-08 Janssen Sciences Ireland Unlimited Company Co Cork, IE Cycloalkyl substituted pyrazolopyrimidines having activity against RSV
WO2019206828A1 (fr) 2018-04-23 2019-10-31 Janssen Sciences Ireland Unlimited Company Composés hétéroaromatiques ayant une activité contre vrs
WO2020051498A1 (fr) 2018-09-06 2020-03-12 Cidara Therapeutics, Inc. Compositions et procédés pour le traitement d'infections virales
MA54092A (fr) 2018-10-30 2021-09-08 Kronos Bio Inc Composés, compositions et procédés de modulation de l'activité de cdk9
WO2020138015A1 (fr) 2018-12-27 2020-07-02 大正製薬株式会社 Composé macrocyclique de pyrazolo[1,5-a] pyrimidine
WO2021050612A1 (fr) * 2019-09-09 2021-03-18 Cidara Therapeutics, Inc. Compositions et méthodes pour le traitement du virus respiratoire syncytial
CN116425754A (zh) * 2021-12-30 2023-07-14 苏州爱科百发生物医药技术有限公司 芳杂双环化合物及其抗病毒用途

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3361306A (en) 1966-03-31 1968-01-02 Merck & Co Inc Aerosol unit dispensing uniform amounts of a medically active ingredient
US3565070A (en) 1969-02-28 1971-02-23 Riker Laboratories Inc Inhalation actuable aerosol dispenser
FR2224175B1 (fr) 1973-04-04 1978-04-14 Isf Spa
US4069819A (en) 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
IT1017153B (it) 1974-07-15 1977-07-20 Isf Spa Apparecchio per inalazioni
SE438261B (sv) 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
US4805811A (en) 1985-03-29 1989-02-21 Aktiebolaget Draco Dosage device
SE448277B (sv) 1985-04-12 1987-02-09 Draco Ab Indikeringsanordning vid en doseringsanordning for lekemedel
IT1228459B (it) 1989-02-23 1991-06-19 Phidea S R L Inalatore con svuotamento regolare e completo della capsula.
US4955371A (en) 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
AU662919B2 (en) 1991-07-02 1995-09-21 Inhale, Inc. Method and device for delivering aerosolized medicaments
US5261538A (en) 1992-04-21 1993-11-16 Glaxo Inc. Aerosol testing method
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5388572A (en) 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5543413A (en) * 1994-02-25 1996-08-06 Regents Of The University Of Michigan Heterocyclic thioamides and related analogs as antiviral agents with a unique mode of action
US6342501B1 (en) * 1994-02-25 2002-01-29 The Regents Of The University Of Michigan Pyrrolo[2,3-d] pyrimidines as antiviral agents
PL318199A1 (en) 1994-06-29 1997-05-26 Smithkline Beecham Corp Antagonists of vitronectin receptors
US5522385A (en) 1994-09-27 1996-06-04 Aradigm Corporation Dynamic particle size control for aerosolized drug delivery
US5622163A (en) 1994-11-29 1997-04-22 Iep Group, Inc. Counter for fluid dispensers
US5544647A (en) 1994-11-29 1996-08-13 Iep Group, Inc. Metered dose inhalator
CN1297447A (zh) 1998-02-17 2001-05-30 图拉列克股份有限公司 抗病毒嘧啶衍生物
US6116234A (en) 1999-02-01 2000-09-12 Iep Pharmaceutical Devices Inc. Metered dose inhaler agitator
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
EP1485384A1 (fr) 2002-03-13 2004-12-15 Pharmacia & Upjohn Company LLC Derives de pyrazolo(1,5-a)pyridine utilises en tant que modulateurs du neurotransmetteur
US7304068B2 (en) * 2002-05-10 2007-12-04 Smithkline Beecham Corporation Substituted pyrazolo [1,5-A] pyrimidinyls and pharmaceutical uses therefore
ATE389656T1 (de) 2002-06-04 2008-04-15 Neogenesis Pharmaceuticals Inc Pyrazolo(1,5-a)pyrimidin-verbindungen als antivirale agentien
DE10247271A1 (de) 2002-10-10 2004-08-26 Grünenthal GmbH Substituierte C-Imidazo[1,2-a]pyridin-3-yle
EP2287167A1 (fr) * 2003-12-24 2011-02-23 Biota Scientific Management Pty. Ltd. Agents polycycliques pour le traitement des infections de virus respiratoire syncytial
SG133452A1 (en) 2005-12-30 2007-07-30 Novartis Ag Peptide deformylase inhibitors for treatment of mycobacterial and other parasitic diseases
EP2097405A2 (fr) 2006-11-21 2009-09-09 Smithkline Beecham Corporation Composés anti-viraux
CA2709109A1 (fr) 2007-12-13 2009-06-18 Alnylam Pharmaceuticals Inc. Procedes et compositions de prevention ou de traitement d'infection a virus respiratoire syncytial (rsv)
CA2709883A1 (fr) 2007-12-19 2009-06-25 The Scripps Research Institute Benzimidazoles et analogues comme inhibiteurs de la rho-kinase
EA201001359A1 (ru) 2008-02-26 2011-04-29 Новартис Аг Гетероциклические соединения в качестве ингибиторов cxcr2
JP5637982B2 (ja) 2008-04-09 2014-12-10 インフィニティー ファーマシューティカルズ， インコーポレイテッド 脂肪酸アミド加水分解酵素の阻害剤
US20110275673A1 (en) 2008-09-19 2011-11-10 Yibin Xiang Inhibitors of sphingosine kinase 1
EP2182081B1 (fr) 2008-10-29 2014-01-22 Neue Materialien Bayreuth GmbH Procédé destiné au traitement thermique d'un corps en tôle d'acier revêtu
BRPI0922366B8 (pt) 2008-12-03 2021-05-25 Presidio Pharmaceuticals Inc composto, composição farmacêutica e uso de um composto
US8609696B2 (en) 2008-12-18 2013-12-17 Boehringer Ingelheim International Gmbh Serotonin 5-HT2B receptor inhibitors
SG172352A1 (en) 2008-12-23 2011-07-28 Abbott Lab Anti-viral compounds
TWI438200B (zh) 2009-02-17 2014-05-21 必治妥美雅史谷比公司 Ｃ型肝炎病毒抑制劑
SG174146A1 (en) 2009-02-27 2011-10-28 Enanta Pharm Inc Hepatitis c virus inhibitors
US8889674B2 (en) 2009-03-05 2014-11-18 Shionogi & Co., Ltd. Piperidine and pyrrolidine derivatives having NPY Y5 receptor antagonism
NZ591973A (en) 2009-06-11 2013-03-28 Abbott Lab Anti-viral compounds to treat hcv infection
US8221737B2 (en) 2009-06-16 2012-07-17 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
WO2010148006A1 (fr) 2009-06-16 2010-12-23 Enanta Pharmaceuticals, Inc. Inhibiteurs du virus de l'hépatite c
BR112012002662A2 (pt) 2009-08-07 2016-03-22 Tibotec Pharm Ltd derivados de bis-benzimidazol
US20110274648A1 (en) 2009-11-11 2011-11-10 Bristol-Myers Squibb Company Hepatitis C Virus Inhibitors
WO2011099832A2 (fr) 2010-02-12 2011-08-18 Crystalgenomics, Inc. Nouveau composé de benzimidazole, son procédé de préparation et composition pharmaceutique le contenant
US8877707B2 (en) 2010-05-24 2014-11-04 Presidio Pharmaceuticals, Inc. Inhibitors of HCV NS5A
ES2700542T3 (es) 2010-06-24 2019-02-18 Gilead Sciences Inc Composición farmacéutica que comprende un derivado de pirazolo[1,5-A]pirimidina como un agente antiviral
EP2595980B1 (fr) 2010-07-22 2014-09-03 Gilead Sciences, Inc. Procédés et composés pour traiter des infections à virus paramyxoviridae
PT2794611T (pt) 2011-12-22 2017-12-06 Gilead Sciences Inc Pirazolo[1,5-a]pirimidinas como agentes antivirais
IN2014DN09173A (fr) 2012-04-17 2015-07-10 Gilead Sciences Inc

Also Published As

Publication number Publication date
PL2585467T3 (pl) 2016-09-30
CA2800834A1 (fr) 2011-12-29
US8809330B2 (en) 2014-08-19
HUE029174T2 (hu) 2017-02-28
ES2700542T3 (es) 2019-02-18
AU2011270798B2 (en) 2015-03-19
US8486938B2 (en) 2013-07-16
AR082275A1 (es) 2012-11-28
KR101970837B1 (ko) 2019-04-19
RS54761B1 (sr) 2016-10-31
TWI626050B (zh) 2018-06-11
EP2585467B1 (fr) 2016-03-02
US20140154240A1 (en) 2014-06-05
IL257410A (en) 2018-04-30
PE20130395A1 (es) 2013-04-10
EA023223B1 (ru) 2016-05-31
JP2015218176A (ja) 2015-12-07
AP3417A (en) 2015-09-30
EA201591390A1 (ru) 2016-06-30
HK1221715A1 (zh) 2017-06-09
US9238039B2 (en) 2016-01-19
HK1184157A1 (zh) 2014-01-17
US9957275B2 (en) 2018-05-01
ECSP13012400A (es) 2013-03-28
TW201529578A (zh) 2015-08-01
HRP20160431T1 (hr) 2016-05-20
ES2571334T3 (es) 2016-05-24
ECSP17084267A (es) 2018-01-31
CL2012003632A1 (es) 2013-11-04
DK2585467T3 (en) 2016-06-13
JP2017019850A (ja) 2017-01-26
TWI537272B (zh) 2016-06-11
TWI476201B (zh) 2015-03-11
CA2800834C (fr) 2018-10-23
CN105481866A (zh) 2016-04-13
ME02397B (fr) 2016-09-20
IL223253B (en) 2018-02-28
BR112012033117A2 (pt) 2016-11-22
JP5878171B2 (ja) 2016-03-08
TW201639576A (zh) 2016-11-16
US20170190708A1 (en) 2017-07-06
IL223253A0 (en) 2013-02-03
SG10201505022WA (en) 2015-07-30
EP3012258B1 (fr) 2018-09-19
AP2013006686A0 (en) 2013-01-31
CY1118239T1 (el) 2017-06-28
AU2011270798A1 (en) 2013-01-24
JP2020059750A (ja) 2020-04-16
MX2012015292A (es) 2013-05-30
US20120003215A1 (en) 2012-01-05
HK1223934A1 (zh) 2017-08-11
JP6684552B2 (ja) 2020-04-22
NZ604345A (en) 2015-02-27
EP3012258A1 (fr) 2016-04-27
US20180298011A1 (en) 2018-10-18
EP2585467A1 (fr) 2013-05-01
WO2011163518A1 (fr) 2011-12-29
CN102958933A (zh) 2013-03-06
UY33467A (es) 2012-01-31
US20170362244A1 (en) 2017-12-21
CN102958933B (zh) 2016-02-03
TW201213332A (en) 2012-04-01
US20140072554A1 (en) 2014-03-13
CR20130023A (es) 2013-03-25
SI2585467T1 (sl) 2016-04-29
PT3012258T (pt) 2018-12-14
JP2013534524A (ja) 2013-09-05
KR20140032333A (ko) 2014-03-14
ZA201209549B (en) 2015-07-29
CO6640297A2 (es) 2013-03-22
EA201291172A1 (ru) 2013-05-30
US20160130275A1 (en) 2016-05-12
SMT201600155B (it) 2016-07-01
UA112292C2 (uk) 2016-08-25
SG186291A1 (en) 2013-02-28

Similar Documents

Publication Publication Date Title
MA34392B1 (fr) Pyrimidines en tant qu'agents antiviraux
MA37942A2 (fr) Hétéroaryldihydropyrimidines d'acide 6-aminé pour le traitement et la prophylaxie d'une infection par le virus de l'hépatite b
MA37712A2 (fr) Inhibiteurs macrocycliques de virus flaviviridae
MA41134B1 (fr) Composés substitués de 5-amino-6h-thiazolo[4,5-d]pyrimidine-2,7-dione pour le traitement et la prophylaxie des infections virales
IN2014CN00562A (fr)
MA35750B1 (fr) Dérivés de nucléoside substitué 2',4'-difluoro-2'-méthyle en tant qu'inhibiteurs de la réplication de l'arn du vhc (virus de l'hépatite c)
MA34470B1 (fr) Procédés et composés pour traiter des infections à virus paramyxoviridae
EA201391495A1 (ru) Производные пиримидина для лечения вирусных инфекций
MA35132B1 (fr) 4-aryl-n-phényl-1,3,5-triazine-2- amines contenant un groupe sulfoximine
MA37400B1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
PH12015501678A1 (en) Inhibitors of influenza viruses replication
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
CR20130560A (es) Compuestos de bezotiazol y su uso farmacéutico
EA201001508A1 (ru) Мостиковые гетероциклические соединения в качестве ингибиторов интегразы вич
EA201070988A1 (ru) Противовирусные терапевтические средства
EA201391719A1 (ru) Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
MA34819B1 (fr) Dérivés bicyclo[3.2.1]octylamide et leurs utilisations
EA200971096A1 (ru) Терапевтические композиции и их применение
MX2013011691A (es) Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos.
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
EA201270492A1 (ru) Соединения для лечения дислипидемии и связанных с ней заболеваний
MA38315A1 (fr) Composés tétracycliques substitués par un hétérocycle et procédés pour les utiliser pour le traitement de maladies virales
MA35895B1 (fr) Inhibiteurs d'iap
EA201170605A1 (ru) Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства